NCT00064077View on ClinicalTrials.gov

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

PHASE3CompletedINTERVENTIONAL

Enrollment

513

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

January 31, 2011

Study Completion Date

January 30, 2018

Conditions

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaRecurrent Cervical CarcinomaStage IVB Cervical Cancer

Interventions

DRUG

Cisplatin

Given IV

DRUG

Gemcitabine Hydrochloride

DRUG

Paclitaxel

Given IV

OTHER

Quality-of-Life Assessment

Ancillary studies

DRUG

Topotecan Hydrochloride

Given IV

DRUG

Vinorelbine Tartrate

Given IV

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00064077 - Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | Biotech Hunter | Biotech Hunter